Old Web
English
Sign In
Acemap
>
authorDetail
>
Marja Niiranen
Marja Niiranen
Multiple sclerosis
Natalizumab
Internal medicine
Medicine
Oncology
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis
2021
Multiple sclerosis and related disorders
Marja Niiranen
Aleksi Kontkanen
Olli Jaaskelainen
H-M. Tertsunen
Tuomas Selander
Päivi Hartikainen
Nadine Huber
Eino Solje
Annakaisa Haapasalo
Tarja Kokkola
T. Lohioja
S.-K. Herukka
Sakari Simula
Am. Remes
Show All
Source
Cite
Save
Citations (0)
Corrigendum to “Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation” [Multiple Sclerosis and Related Disorders 38 (2020) 101498]
2020
Multiple sclerosis and related disorders
Tiina Mustonen
Ilkka Rauma
Päivi Hartikainen
Johanna Krüger
Marja Niiranen
Tuomas Selander
Sakari Simula
Anne M. Remes
Hanna Kuusisto
Show All
Source
Cite
Save
Citations (0)
Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation
2019
Multiple sclerosis and related disorders
Tiina Mustonen
Ilkka Rauma
Päivi Hartikainen
Johanna Krüger
Marja Niiranen
Tuomas Selander
Simula Simula
Anne M. Remes
Hanna Kuusisto
Show All
Source
Cite
Save
Citations (2)
1